JPRN-UMIN000007619已完成4 期
Efficacy and safety of glycemic control in type 2 diabetes patients when switched to mitiglinide/voglibose fixed-dose combination therapy. - Efficacy and safety of mitiglinide/voglibose fixed-dose combination therapy.
Keio University School of Medicine Department of Nephrology, Endocrinology and Metabolism0 个研究点目标入组 15 人开始时间: 2012年4月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Contraindicated for mitiglinide or voglibose. 2)Patients who received glinide or alpha GI more than daily dose*. (Daily dose: mitiglinide 10mg/time, nateglinide 90mg/time, voglibose 0.3mg/time, acarbose 100mg/time, miglitol 50mg/time) 3)Patients who had been previously receiving DPP4 inhibitor or GLP-1 analogue, insulin. 4)Anticipated to be non-compliant to the trial by principal investigators opinion.
研究者
相似试验
招募中
不适用
An observational study to compare blood glucose level and adverse effects in Type 2 diabetic patients receiving Basal-bolus insulin regimen versus Premixed insulin regimen.CTRI/2021/06/033914Institute of Postgraduate Medical Education and Research and SSKM Hospital Kolkata
招募中
不适用
Improving glycaemic control of patients with type 2 diabetes mellitus (T2DM) through management by a community based, multidisciplinary, integrated primary care / specialist level care service.Type 2 diabetes mellitus (T2DM)Recognised complications of T2DMType 2 diabetes mellitus (T2DM)Recognised complications of T2DMMetabolic and Endocrine - DiabetesPublic Health - Health service researchACTRN12608000010392Community & Primary Health Services, Queensland Health250
尚未招募
不适用
Glycemic control of in patient type2 diabetes mellitus comparing between Thammasart insulin protocol and routine care: randomized-controlled trialInhospital hyperglycemiaInsulinDiabetes millitusTCTR20180316006one90
尚未招募
3 期
Comparison of efficacy and safety of different doses of metformin in women with gestational diabetes mellitusCTRI/2023/11/059803All India Institute of Medical Sciences New Delhi
招募中
不适用
Efficacy and safety in SGLT2 inhibitor for diabetes complicated by non-alcoholic fatty liver disease.Type 2 diabetes complicated by non-alcoholic fatty liver diseaseJPRN-UMIN000018166Toranomon Hospital, Department of Hepatology15